OLMA - Company ID 0001750284
The table below shows Olema Pharmaceuticals, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $48.30M | $139.48M | $68.54M | $23.70M | $13.81M |
| Short-term investments | $457.14M | $294.61M | $193.27M | $180.72M | $273.44M |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | $515.45M | $438.47M | $266.51M | $208.90M | $290.69M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment | $274.00K | $746.00K | $968.00K | $1.48M | $1.47M |
| Goodwill | - | - | - | - | - |
| Total assets | $533.43M | $450.98M | $276.94M | $215.65M | $295.94M |
| Accounts payable | $9.25M | $4.46M | $2.70M | $374.00K | $23.00K |
| Total current liabilities | $51.80M | $41.76M | $21.62M | $16.55M | $9.02M |
| Long-term debt | - | - | - | - | - |
| Total liabilities | $54.87M | $42.02M | $23.05M | $18.10M | $11.38M |
| Retained earnings | -$597.56M | -$435.11M | -$305.63M | -$208.98M | -$104.19M |
| Total equity | $478.56M | $408.96M | $253.90M | $197.55M | $284.57M |